Last reviewed · How we verify
NCT06672770
Effect of Functional Inspiratory Muscle Training in Patients with Multiple Sclerosis
NA trial testing Functional Inspiratory Muscle Training in Core Muscles in 63 participants. Not yet recruiting.
31 October 2025
Quick facts
| Lead sponsor | Selcuk University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 1 November 2024 |
| Primary completion | 31 October 2025 |
| Estimated completion | 20 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Functional Inspiratory Muscle Training
- Basic Inspiratory Muscle Training
Conditions studied
- Core Muscles — all drugs for Core Muscles →
- Functional Inspiratory Muscle Training — all drugs for Functional Inspiratory Muscle Training →
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
- Respiratory Muscles — all drugs for Respiratory Muscles →
Sponsor
Selcuk University
Who can join
Adults 18 to 65, any sex, with Core Muscles or Functional Inspiratory Muscle Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the effects of functional inspiratory muscle training, basic inspiratory muscle training and physical activity in addition to respiratory exercises on respiratory muscle strength, respiratory function, cognition, walking, balance, functional exercise capacity, physical activity, quality of life and core muscles in volunteer Multiple Sclerosis (MS) patients. This study is planned as a prospective, randomized and experimental study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06672770
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Functional Inspiratory Muscle Training
Trials testing the same drug.
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07061444 — Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients · NA · recruiting
- NCT06454539 — The Effect of Functional Inspiratory Muscle Training Versus Inspiratory Muscle Training · NA · completed
- NCT06280183 — Functional Inspiratory Muscle Training in Obese Individuals · NA · completed
- NCT04958759 — Functional Inspiratory Muscle Training in Chronic Kidney Disease · NA · completed
Other Selcuk University trials
Trials by the same sponsor.
- NCT07402499 — Validation of a Virtual Reality Timed Up and Go Test in Adults With Chronic Non-Specific Low Back Pain · not yet recruiting
- NCT07364591 — Immediate Effect of Kinesiotaping With Rounded Shoulder Posture in University Students · NA · not yet recruiting
- NCT07381244 — Validity, Reliability, and Clinical Correlates of Immersive Virtual Reality Adaptation of the Five Times Sit-to-stand Te · not yet recruiting
- NCT07373704 — Respiratory Muscle Strength and Endurance Cut-Offs in Multiple Sclerosis · not yet recruiting
- NCT07362368 — Virtual Reality-Based Five-Repetition Sit-to-Stand Test in Young Adults · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06672770 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Selcuk University
- Last refreshed: 4 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06672770.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing